logo

Allergan Inc. (AGN)



Trade AGN now with
  Date
  Headline
9/17/2019 7:32:46 AM Allergan Reports Commencement Of Mailing Of Proxy Statement
9/9/2019 7:34:18 AM Allergan, Molecular Announce Acceptance Of FDA BLA,Validation Of EMA Marketing Authorisation For Abicipar Pegol
9/3/2019 7:31:58 AM Allergan Gets FDA Approval Of Juvéderm VOLUMA® XC For Mid-Face Injection Via Cannula
8/30/2019 7:01:30 AM Allergan Reaches Settlement With Two Ohio Plaintiffs In Federal Opioid Litigation
8/22/2019 9:01:57 AM Amgen And Allergan Announce Positive Top-line Results From Comparative Clinical Study Evaluating ABP 798
8/6/2019 7:27:24 AM Allergan Inc. (AGN) Has Raised Its FY19 Revenue Estimate To $15.40 - $15.60 Bln From $15.10 - $15.40 Bln
8/6/2019 7:02:26 AM Allergan Q2 Non-GAAP Performance EPS $4.38 Vs $4.42 Last Year
7/24/2019 8:37:04 AM Allergan Recalls BIOCELL Textured Breast Implants And Tissue Expanders
7/19/2019 7:40:24 AM Allergan Inc. (AGN) Declares Quarterly Dividend of $ 0.74, Record Date 8/13/2019
7/19/2019 7:32:36 AM Allergan Declares Q3 Cash Dividend Of $0.74/shr; Payable September 13/record August 13
7/18/2019 11:01:52 PM Amgen And Allergan's MVASI And KANJINTI Now Available In US
7/17/2019 7:31:57 AM Allergan Says FDA Accepted NDA For Bimatoprost Sustained-Release